NO943703D0 - Sammensetninger og fremgangsmåter for bestemmelse av proteinstrukturer - Google Patents

Sammensetninger og fremgangsmåter for bestemmelse av proteinstrukturer

Info

Publication number
NO943703D0
NO943703D0 NO943703A NO943703A NO943703D0 NO 943703 D0 NO943703 D0 NO 943703D0 NO 943703 A NO943703 A NO 943703A NO 943703 A NO943703 A NO 943703A NO 943703 D0 NO943703 D0 NO 943703D0
Authority
NO
Norway
Prior art keywords
labeled
protein
amino acid
acid mixture
subjecting
Prior art date
Application number
NO943703A
Other languages
English (en)
Other versions
NO943703L (no
Inventor
Jonathan Miles Brown
Original Assignee
Martek Biosciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21764312&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO943703(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Martek Biosciences Corp filed Critical Martek Biosciences Corp
Publication of NO943703D0 publication Critical patent/NO943703D0/no
Publication of NO943703L publication Critical patent/NO943703L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/12—Unicellular algae; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/534—Production of labelled immunochemicals with radioactive label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO943703A 1993-02-05 1994-10-04 Sammensetninger og fremgangsmåter for bestemmelse av proteinstrukturer NO943703L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/014,243 US5393669A (en) 1993-02-05 1993-02-05 Compositions and methods for protein structural determinations
PCT/US1994/001329 WO1994018339A1 (en) 1993-02-05 1994-02-07 Compositions and methods for protein structural determinations

Publications (2)

Publication Number Publication Date
NO943703D0 true NO943703D0 (no) 1994-10-04
NO943703L NO943703L (no) 1994-11-23

Family

ID=21764312

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943703A NO943703L (no) 1993-02-05 1994-10-04 Sammensetninger og fremgangsmåter for bestemmelse av proteinstrukturer

Country Status (13)

Country Link
US (3) US5393669A (no)
EP (3) EP0636183B1 (no)
JP (4) JPH07506192A (no)
AT (1) ATE221918T1 (no)
AU (2) AU678446B2 (no)
CA (1) CA2129904A1 (no)
DE (1) DE69431142T2 (no)
DK (1) DK0636183T3 (no)
ES (1) ES2181715T3 (no)
FI (1) FI112116B (no)
NO (1) NO943703L (no)
PT (1) PT636183E (no)
WO (1) WO1994018339A1 (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5393669A (en) * 1993-02-05 1995-02-28 Martek Biosciences Corp. Compositions and methods for protein structural determinations
US5891643A (en) * 1995-11-14 1999-04-06 Abbott Laboratories Use of nuclear magnetic resonance to design ligands to target biomolecules
US5989827A (en) * 1995-11-14 1999-11-23 Abbott Laboratories Use of nuclear magnetic resonance to design ligands to target biomolecules
DK0870197T4 (da) * 1995-11-14 2007-02-26 Abbott Lab Anvendelse af nuclear magnetisk resonans til design af ligander rettet mod biomolekyler
AU7731696A (en) * 1995-11-15 1997-06-05 Martek Corporation Photosynthetic production of stable isotopically labeled recombinant proteins
US6168912B1 (en) 1996-01-23 2001-01-02 Martek Biosciences Corporation Method and kit for making a multidimensional combinatorial chemical library
US6111066A (en) 1997-09-02 2000-08-29 Martek Biosciences Corporation Peptidic molecules which have been isotopically substituted with 13 C, 15 N and 2 H in the backbone but not in the sidechains
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
WO2000040988A1 (en) * 1998-12-30 2000-07-13 Nycomed Amersham Plc Nmr spectroscopic in vitro assay using hyperpolarization
AU5880800A (en) * 1999-06-25 2001-01-31 Battelle Memorial Institute Use of non-lossy solvents as a means to improve the high-field nmr sensitivity of biological samples
ATE344456T1 (de) 2000-05-05 2006-11-15 Purdue Research Foundation Durch affinität ausgewählte unterschriftspeptide zur identifizierung und quantifizierung von proteinen
US6762041B2 (en) * 2000-05-15 2004-07-13 Ajinomoto Co., Inc. Method for isotope labeling of protein with enzyme
US6882939B2 (en) * 2000-10-20 2005-04-19 Prospect Pharma Rapid determination of protein global folds
AU2002224440A1 (en) * 2000-10-20 2002-05-06 Martek Biosciences Corporation Rapid determination of protein global folds
US20030068650A1 (en) * 2001-03-12 2003-04-10 Jack Greenblatt Target analysis for chemistry of specific and broad spectrum anti-infectives and other therapeutics
US7256047B2 (en) * 2001-05-01 2007-08-14 Board Of Regents, The University Of Texas System Measurement of gluconeogenesis and intermediary metabolism using stable isotopes
WO2003006488A1 (en) * 2001-07-13 2003-01-23 The Regents Of The University Of California In-cell nmr spectroscopy
AU2002325755A1 (en) * 2001-09-18 2003-04-01 Affinium Pharmaceuticals, Inc. Methods and apparatuses for purification
US7449170B2 (en) * 2001-09-27 2008-11-11 Purdue Research Foundation Materials and methods for controlling isotope effects during fractionation of analytes
NZ531944A (en) 2001-10-19 2006-03-31 Isotechnika Inc Synthesis of cyclosporin analogs
DK1457482T3 (da) * 2001-12-19 2012-02-27 Japan Science & Tech Agency Stabil isotop-mærket aminosyre, fremgangsmåde til integrering af samme i målprotein, fremgangsmåde til NMR-strukturanalyse af protein
US20050079526A1 (en) * 2002-02-20 2005-04-14 Affinium Pharmaceuticals, Inc. Methods and apparatuses for characterizing refolding and aggregation of biological molecules
CA2477021A1 (en) * 2002-02-20 2003-08-28 Affinium Pharmaceuticals, Inc. Methods and apparatuses for characterizing stability of biological molecules
US20050181464A1 (en) * 2002-04-04 2005-08-18 Affinium Pharmaceuticals, Inc. Novel purified polypeptides from bacteria
WO2003087834A2 (en) * 2002-04-08 2003-10-23 Affinium Pharmaceuticals, Inc. High throughput analysis of recombinant proteins in multi-well plates
NO20023357D0 (no) * 2002-04-19 2002-07-11 Amersham Health As Blanding
WO2003104430A2 (en) * 2002-06-10 2003-12-18 Prospect Pharma Method for obtaining dynamic and structural data pertaining to proteins and protein/ligand complexes
US20040121445A1 (en) * 2002-07-31 2004-06-24 Fabien Marino Cell cultures
US20070184455A1 (en) * 2003-05-16 2007-08-09 Cheryl Arrowsmith Evaluation of spectra
AU2004256368B2 (en) * 2003-07-11 2010-08-05 Tatiana A. Egorova-Zachernyuk Compositions and methods for stable isotope labelling of biological compounds
WO2005037853A2 (en) * 2003-10-07 2005-04-28 Prospect Pharma Side chain deuterated amino acids and methods of use
WO2005042469A1 (ja) * 2003-10-31 2005-05-12 Japan Science And Technology Agency 安定同位体標識芳香族アミノ酸、その標的蛋白質への組み込み方法並びに蛋白質のnmr構造解析方法
PL2447356T3 (pl) 2005-06-07 2016-10-31 Mikroorganizmy eukariotyczne do wytwarzania lipidów i przeciwutleniaczy
GB0604647D0 (en) 2006-03-08 2006-04-19 Shchepinov Mikhail Stabilized food supplements and their derivatives
EP2043970B1 (en) * 2006-07-05 2018-04-18 Centre National De La Recherche Scientifique (C.N.R.S.) Iron-copper co-catalyzed process for carbon-carbon or carbon-heteroatom bonding
CN101981201A (zh) * 2006-08-01 2011-02-23 加拿大海洋营养食品有限公司 产油微生物及改良这些微生物的方法
DE102011007790A1 (de) * 2011-04-20 2012-10-25 Wacker Chemie Ag Verfahren zur Reinigung von L-Cystein
CN105189740B (zh) 2013-03-13 2019-01-15 帝斯曼营养品股份公司 工程化微生物
US20140260586A1 (en) * 2013-03-14 2014-09-18 Schlumberger Technology Corporation Method to perform rapid formation fluid analysis
JP2015067581A (ja) * 2013-09-30 2015-04-13 国立大学法人京都大学 多重共鳴用のプローブ
US20160299090A1 (en) * 2013-11-13 2016-10-13 Nanonord A/S A method for quantitative determination of nitrogen in an aqueous fluid
CN104030942B (zh) * 2014-06-09 2016-08-24 浙江普洛医药科技有限公司 一种L-α-氨基丁酰胺盐酸盐的制备方法
US20190084900A1 (en) * 2016-05-02 2019-03-21 Retrotope, Inc. Isotopically modified composition and therapeutic uses thereof
CN107793209A (zh) * 2016-08-30 2018-03-13 泰生科技香港有限公司 稳定性同位素标记植物的专用培养基、其制备方法及用途
JOP20190097A1 (ar) 2016-10-27 2019-04-28 Janssen Pharmaceutica Nv الجلوبولينات المناعية واستخداماتها

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182656A (en) * 1976-09-10 1980-01-08 Johnston Laboratories, Inc. Method for detecting the presence of biologically active agents utilizing 13 C-labeled substrates
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
JPS5811857A (ja) * 1981-07-15 1983-01-22 Yamasa Shoyu Co Ltd アデノシンの定量法
ES2102984T3 (es) * 1989-06-14 1997-08-16 Martek Corp Medios para el crecimiento de celulas y procedimiento para preparar los mismos.
JP2517688B2 (ja) * 1989-12-25 1996-07-24 日本電子株式会社 ３次元核磁気共鳴スペクトルの対称化処理方法
JPH0446143A (ja) * 1990-06-11 1992-02-17 Hitachi Ltd 同位体多重標識アミノ酸の合成法
US5393669A (en) * 1993-02-05 1995-02-28 Martek Biosciences Corp. Compositions and methods for protein structural determinations
US5478729A (en) * 1994-04-28 1995-12-26 Syntex (U.S.A.) Inc. Immunoassay for homocysteine

Also Published As

Publication number Publication date
EP1193271A2 (en) 2002-04-03
US5817474A (en) 1998-10-06
NO943703L (no) 1994-11-23
FI943745A (fi) 1994-08-15
JP2004125801A (ja) 2004-04-22
DE69431142T2 (de) 2003-10-09
DK0636183T3 (da) 2002-12-02
EP0636183A4 (en) 1997-01-22
EP0636183B1 (en) 2002-08-07
JP2004113248A (ja) 2004-04-15
EP0636183A1 (en) 1995-02-01
CA2129904A1 (en) 1994-08-18
AU711468B2 (en) 1999-10-14
ATE221918T1 (de) 2002-08-15
AU678446B2 (en) 1997-05-29
EP1191033A3 (en) 2003-07-30
EP1191033A2 (en) 2002-03-27
FI943745A0 (fi) 1994-08-15
US5627044A (en) 1997-05-06
DE69431142D1 (de) 2002-09-12
JPH07506192A (ja) 1995-07-06
EP1193271A3 (en) 2004-03-24
US5393669A (en) 1995-02-28
JP2004115528A (ja) 2004-04-15
AU6236394A (en) 1994-08-29
ES2181715T3 (es) 2003-03-01
FI112116B (fi) 2003-10-31
WO1994018339A1 (en) 1994-08-18
AU3608797A (en) 1997-12-04
PT636183E (pt) 2002-11-29

Similar Documents

Publication Publication Date Title
NO943703D0 (no) Sammensetninger og fremgangsmåter for bestemmelse av proteinstrukturer
DE69112207D1 (en) "walk-through"-mutagenese.
WO1990010709A3 (en) Monoclonal antibodies for metallic cations on small molecules
ATE170630T1 (de) Proteine mit geänderten epitopen und verfahren zur deren herstellung
ES2054019T5 (es) Procedimiento para la purificacion de proteinas dependientes de la vitamina k.
FI92404B (fi) Menetelmä seerumin albumiinin puhdistamiseksi
DE59208982D1 (de) Verfahren zur Reinigung von IgG-monoklonalen Antikörpern
ATE173274T1 (de) Basen-tumorzellen behandlungsverfahren
DK16196A (da) Fremgangsmåde til fremstilling af glycosphingolipider
FI103974B1 (fi) Menetelmä proteiinin puhdistamiseksi
GR3032396T3 (en) Process for the purification of serum albumin.
ES2059854T3 (es) Nuevo polipeptido y su produccion.
DK0418590T3 (da) Antistoffer, fremstilling deraf og anvendelse deraf
PT1015568E (pt) Metodo para a producao de rdspa alfa1
Brown Compositions and methods for protein structural determinations
EP0539584A4 (no)
DE3584528D1 (de) Katalytisches verfahren zur herstellung von amiden.
DE3865389D1 (de) Verfahren zur herstellung von l,l oder d,d oder racemat n6 benzyloxycarbonyl 2,6 diaminopimelinsaeuremonoamid.
HUT61619A (en) Method for radioimmunological derminic 5-hydroxi- 6,8,11,14-eicosatetraen- acid content of the biological samples
EP0661541A3 (de) Verfahren zur Herstellung langzeitstabiler klarer Seren.
CA2245554A1 (en) Method for the production of rdspa .alpha.1

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application